Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2013
03/27/2013EP2571883A1 Macrocyclic compounds as trk kinase inhibitors
03/27/2013EP2571882A1 Heterocyclic flaviviridae virus inhibitors
03/27/2013EP2571881A1 Pyrrolopyrazine derivatives as syk and jak inhibitors
03/27/2013EP2571880A1 Pyrrolo [2, 3 - b]pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors
03/27/2013EP2571879A1 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
03/27/2013EP2571876A1 Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
03/27/2013EP2571503A2 Compositions and methods for treating neoplasia, inflammatory disease and other disorders
03/27/2013EP2571361A1 Pyrazolopyrimidine compounds for the treatment of cancer
03/27/2013CN103003369A Metallation enhancements in tumor-imaging and PDT therapy
03/27/2013CN103003282A A process for the preparation of novel porphyrin derivatives and their use as PDT agents and fluorescence probes
03/27/2013CN103003281A Pyrrolo [2, 3 - b] pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors
03/27/2013CN103003280A Deuterated pyrrolopyrimidine compounds as inhibitors of CDK4/6
03/27/2013CN103002898A 6-(1-methyl-1h-pyrazol-4-yl)-3-(2-methyl-2h-indazol-5-ylthio)-[1,2,4] triazolo [4,3-b] pyridazine as a c-met inhibitor
03/27/2013CN102993206A Method for synthesising tetraphenylporphyrin metal complex via one-step process
03/27/2013CN102993205A High-yield purification method for preparation of high-purity sildenafil freebases
03/27/2013CN102993204A Certain chemical entities, compositions and methods
03/27/2013CN102993195A Substitutional-2-(chroman-6-oxyl) thiazole and application thereof as medicine
03/27/2013CN102993095A Seven-element-ring polyhydroxy nitrone and preparation method and application thereof
03/27/2013CN102988368A High-purity texaphyrin metal complex
03/27/2013CN102988362A Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
03/27/2013CN102153556B Triazolopyrimidine compound and preparation method thereof
03/27/2013CN101679287B Nicotinic acetylcholine receptor modulators
03/27/2013CN101627028B Substituted diazepan compounds as orexin receptor antagonists
03/27/2013CN101622257B Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-n-methyl-acetamide
03/27/2013CN101610676B Inhibitors of bruton's tyrosine kinase
03/27/2013CN101568542B 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives
03/27/2013CN101525351B Treatment process of glyphosate mother liquor
03/27/2013CN101511834B Compound for organic electroluminescent device and organic electroluminescent device
03/27/2013CN101291935B Novel imidazoquinazoline derivative, process for preparing the same, and organic electronic device using the same
03/26/2013US8404865 Process for preparing azabicyclic compounds
03/26/2013US8404864 Pyrrolopyrrole derivatives, their manufacture and use
03/26/2013US8404860 Compound having hydantoin ring and method of producing the same
03/26/2013US8404852 Gyrase inhibitors and uses thereof
03/26/2013US8404728 Small-molecule botulinum toxin inhibitors
03/26/2013US8404708 Dual NK1/NK3 receptor antagonists
03/26/2013US8404698 Quinazoline derivatives and therapeutic use thereof
03/26/2013US8404694 Aurora kinase modulators and method of use
03/26/2013US8404692 Pyrimidin-4-yl-3, 4-dihydro-2H-pyrrolo [1,2A] pyrazin-1-one compounds
03/26/2013US8404683 Inhibitors of the interaction between MDM2 and P53
03/26/2013US8404678 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
03/21/2013WO2013040528A1 Antimicrobial compounds
03/21/2013WO2013040527A1 Antimicrobial compounds
03/21/2013WO2013039785A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease
03/21/2013WO2013039073A1 Aromatic amine derivative and organic electroluminescence element using same
03/21/2013WO2013037942A1 Synthesis of triazolopyrimidine compounds
03/21/2013WO2013037809A1 Tetrahydrotriazolopyrimidine derivatives as human neutrophil elastase inhibitors
03/21/2013WO2013037724A1 Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
03/21/2013WO2013036994A1 Compounds for the treatment of hcv
03/21/2013US20130072687 Process for Preparing Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
03/21/2013US20130072679 Dihydroquinoline-2-one derivatives
03/21/2013US20130072503 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
03/21/2013US20130072500 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
03/21/2013US20130072495 Fused bicyclic kinase inhibitors
03/21/2013US20130072494 Inhibitors of jun n-terminal kinase
03/21/2013US20130072493 N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS
03/21/2013US20130072492 Soluble guanylate cyclase activators
03/21/2013US20130072481 mTOR SELECTIVE KINASE INHIBITORS
03/21/2013US20130072472 Noribogaine salt ansolvates
03/21/2013US20130072470 Novel tricyclic compounds
03/21/2013US20130072468 Substituted piperazines as cb1 antagonists
03/21/2013US20130072457 Pyrazolyl quinazoline kinase inhibitors
03/21/2013US20130072449 Lysophosphatidic acid receptor antagonists
03/21/2013US20130072427 Gpr 119 modulators
03/21/2013US20130071415 Heterocyclic Compounds as Janus Kinase Inhibitors
03/21/2013US20130071354 Modulators of toll-like receptors
03/21/2013US20130069010 Modular supramolecular approach for co-crystallization of donors and acceptors into ordered networks
03/21/2013CA2848621A1 Synthesis of triazolopyrimidine compounds
03/21/2013CA2848557A1 Tetrahydrotriazolopyrimidine derivatives as human neutrophil elastase inhibitors
03/20/2013EP2570415A1 N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals
03/20/2013EP2570414A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues
03/20/2013EP2570405A1 Synthesis of Triazolopyrimidine Compounds
03/20/2013EP2569319A1 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
03/20/2013EP2569316A1 Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases
03/20/2013EP2569315A1 Fused bicyclic kinase inhibitors
03/20/2013EP2569306A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
03/20/2013EP2569302A1 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
03/20/2013EP2569298A1 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
03/20/2013CN102985426A Pyrazolo [1, 5A] pyrimidine and thieno [3, 2B] pyrimidine derivatives as IRAK4 modulators
03/20/2013CN102985425A Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
03/20/2013CN102985424A 5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of jak kinases
03/20/2013CN102985422A Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinases
03/20/2013CN102985405A Heterocyclic compound, and p27 kip1 degradation inhibitor
03/20/2013CN102977110A Asymmetric dendritic metalloporphyrin as well as preparation method and application thereof
03/20/2013CN102977109A Method for separating triethylene diamine from ethanol amine by ionic liquid extraction and distillation
03/20/2013CN102977108A Method for separating triethylene diamine and ethanolamine
03/20/2013CN102977107A Pemetrexed disodium compound and composition thereof
03/20/2013CN102977106A Kappa opioid agonist with peripheral analgesia effect
03/20/2013CN102977105A Synthesis method of 3(methyl),7-diazabicyclooctane
03/20/2013CN102977104A Synthesis of 2,4-dichloro-7-hydroxy-pyrrolo(2,3)pyrimidine
03/20/2013CN102977103A Graphene derivative and preparation method thereof, and organic electroluminescence device
03/20/2013CN102977086A Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842
03/20/2013CN102977029A 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
03/20/2013CN102276800B Triphenylamine unit porphyrin copolymer as well as preparation method and application thereof
03/20/2013CN102206218B Method for purifying high-purity pemetrexed disodium
03/20/2013CN102153557B Chiral center nitrogen heterocyclic carbine precursor salt with quadrol skeleton, synthetic method and application
03/20/2013CN101365702B Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
03/19/2013US8399683 IAP inhibitors
03/19/2013US8399659 Compounds and methods for inhibiting mitotic progression
03/19/2013US8399470 Inhibitors of bruton's tyrosine kinase
03/19/2013US8399467 Substituted triazolo-pyridazine derivatives
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 573